AIN
Normotim

Normotim

location_on Midwest ,  United States

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

US biotech innovator with a patented product and global traction, scaling into an $8.46B US market.
Preclinically tested, innovative compound — lithium ascorbate — for mental health and neuroprotection. Backed by 40+ studies and US-based production.

Highlights

  • Ready-to-scale biotech innovator with traction, targeting an $8.46B US mark
  • 2M+ units sold globally, 54 patents globally, 3 US patents
  • Projected annual return on investment: 60%. We aim to 10x your investment w
  • Preclinically tested, innovative compound. Backed by 40+ studies, US-based

Overview

Target ₹89,000,000
Minimum ₹9,000
Investment Raised ₹90,000
Previous Rounds ₹8,900,000
Stage Achieving Sales
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects